GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nykode Therapeutics AS (OSL:NYKD) » Definitions » Total Long-Term Liabilities

Nykode Therapeutics AS (OSL:NYKD) Total Long-Term Liabilities : kr66.74 Mil (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Nykode Therapeutics AS Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Nykode Therapeutics AS's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was kr66.74 Mil.

Nykode Therapeutics AS Total Long-Term Liabilities Historical Data

The historical data trend for Nykode Therapeutics AS's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nykode Therapeutics AS Total Long-Term Liabilities Chart

Nykode Therapeutics AS Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Long-Term Liabilities
Get a 7-Day Free Trial 330.84 360.45 251.69 172.15 91.65

Nykode Therapeutics AS Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 160.80 134.92 102.00 91.65 66.74

Nykode Therapeutics AS Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Nykode Therapeutics AS Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Nykode Therapeutics AS's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Nykode Therapeutics AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nykode Therapeutics AS (OSL:NYKD) » Definitions » Total Long-Term Liabilities
Comparable Companies
OSL:HBC OSL:AZT OSL:TRMED OSL:LYTIX OSL:ZLNA OSL:ABTEC OSL:ONCIN OSL:SOFTX OSL:EXTX OSL:ABS VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
VACBF:USA NYKDo:Sweden 5VB:Germany
Address
Gaustadalleen 21, Oslo Research Park, Oslo, NOR, 0349
Website
https://www.nykode.com
Nykode Therapeutics AS is a clinical-stage biopharmaceutical company focused on the discovery and development of novel immunotherapies. The company is developing individualized cancer neoantigen vaccines and is using the Vaccibody technology to generate therapeutics to treat cancers with a high unmet medical need. It operates in United States of America.

Nykode Therapeutics AS Headlines

No Headlines